Eurofins Scientific/€ERF
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Eurofins Scientific
Eurofins Scientific, with the ticker ERF, is a global bio-analytical testing providing services across several industries including pharmaceutical, food, environmental, and consumer products. Founded in 1987, the company specializes in delivering analytical testing and advisory services to ensure product safety and compliance with regulations. Eurofins operates through a decentralized network of laboratories, serving customers worldwide to enhance health and safety standards.
Ticker
€ERF
Sector
Primary listing
PAR
Industry
Life Sciences Tools & Services
Headquarters
Luxembourg City, Luxembourg
Employees
62,696
ISIN
FR0014000MR3
Website
ERF Metrics
BasicAdvanced
€11B
33.22
€1.83
0.81
€1.10
0.99%
Price and volume
Market cap
€11B
Beta
0.81
52-week high
€61.50
52-week low
€43.72
Average daily volume
384K
Dividend rate
€1.10
Financial strength
Current ratio
1.162
Quick ratio
1.054
Long term debt to equity
58.154
Total debt to equity
67.038
Dividend payout ratio (TTM)
36.69%
Interest coverage (TTM)
6.13%
Profitability
EBITDA (TTM)
1,366.9
Gross margin (TTM)
22.45%
Net profit margin (TTM)
5.85%
Operating margin (TTM)
12.92%
Effective tax rate (TTM)
26.90%
Revenue per employee (TTM)
€110,000
Management effectiveness
Return on assets (TTM)
5.15%
Return on equity (TTM)
7.70%
Valuation
Price to earnings (TTM)
33.219
Price to revenue (TTM)
1.67
Price to book
2.62
Price to tangible book (TTM)
-8.92
Price to free cash flow (TTM)
14.697
Free cash flow yield (TTM)
6.80%
Free cash flow per share (TTM)
413.61%
Dividend yield (TTM)
1.81%
Forward dividend yield
0.99%
Growth
Revenue change (TTM)
6.70%
Earnings per share change (TTM)
40.77%
3-year revenue growth (CAGR)
1.14%
10-year revenue growth (CAGR)
17.29%
3-year earnings per share growth (CAGR)
-21.13%
10-year earnings per share growth (CAGR)
14.18%
3-year dividend per share growth (CAGR)
-15.66%
10-year dividend per share growth (CAGR)
16.35%
What the Analysts think about ERF
Analyst ratings (Buy, Hold, Sell) for Eurofins Scientific stock.
Bulls say / Bears say
Eurofins Scientific reported a 6.87% year-over-year increase in revenue for Q4 2024, indicating strong financial performance. (Google Finance)
The independent audit by Ernst & Young Paris found no material misstatements in Eurofins' cash statements, refuting earlier allegations by short seller Muddy Waters. (Reuters)
Eurofins' net income increased by 17.01% in Q4 2024, reflecting improved profitability. (Google Finance)
Eurofins slightly lowered its revenue forecast for the full year 2024 to nearly 7 billion euros, down from the previous range of 7.075 to 7.175 billion euros. (Reuters)
The company's cash and short-term investments decreased by 49.74% year-over-year in Q4 2024, potentially impacting liquidity. (Google Finance)
Eurofins' net change in cash was negative 33.65 million euros in Q4 2024, indicating cash outflows. (Google Finance)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.
ERF Financial Performance
Revenues and expenses
ERF Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Eurofins Scientific stock?
Eurofins Scientific (ERF) has a market cap of €11B as of June 30, 2025.
What is the P/E ratio for Eurofins Scientific stock?
The price to earnings (P/E) ratio for Eurofins Scientific (ERF) stock is 33.22 as of June 30, 2025.
Does Eurofins Scientific stock pay dividends?
Yes, the Eurofins Scientific (ERF) stock pays dividends to shareholders. As of June 30, 2025, the dividend rate is €1.1 and the yield is 0.99%. Eurofins Scientific has a payout ratio of 36.69% on a trailing twelve-month basis.
When is the next Eurofins Scientific dividend payment date?
The next Eurofins Scientific (ERF) dividend payment date is unconfirmed.
What is the beta indicator for Eurofins Scientific?
Eurofins Scientific (ERF) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.